Skip to content

Investigator

Kalim Ullah Mir

XGENOMES CORP. · funded by NIGMS, NCI, NHGRI

Companies
2

Resolved onto their grants.

Grants
3

Federal awards on file.

Non-dilutive funding
$1.1M

Summed across those awards.

First award
Jun 1, 2025

Latest Sep 15, 2025.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R43

    Achieving ultra-high-density, ultra-high-precision single molecule localization microscopy with whole-video deep learning architectures

    $349k

    Sep 15, 2025NIGMSXGENOMES CORP.NIH RePORTER · 11185009 (opens the source filing in a new tab)

  2. R43

    A novel ctDNA analysis solution for the next-generation of liquid biopsy assays

    $400k

    Sep 1, 2025NCIXGENOMES CORP.NIH RePORTER · 11254540 (opens the source filing in a new tab)

  3. R43

    Sequencing of epigenetic modifications across the genome by single-molecule detection of oligonucleotide binding kinetics

    $398k

    Jun 1, 2025NHGRIXGENOMES CORP.NIH RePORTER · 11185004 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources